Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
Clinical trial NCT03611946 · COMPLETED
Trial details
- NCT number
- NCT03611946
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-06
- Primary completion
- 2022-03-18
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.